ToPCaP

Smad 4-depedent barrier contrains prostate cancer growth and metastatic progression.

Ding Z, Wu CJ, Chu GC, Xiao Y, Ho D, Zhang J, Perry SR, Wu X, Lis R, Hoshida Y, Hiller D, Hu B, Jiang S, Labrot ES, Zheng H, Stegh AH, Scott KL, Signoretti S, El-Bardessy NM, Wang YA, Hill D, Golub TR, Stampfer MJ, Wong WH, Loda M, Mucci L, Chin L, DePinho RA. SMAD 4-depedent barrier contrains prostate cancer growth and metastatic progression. Nature 2011; 470: 269-73. PMCID: PMC3753179